TRIM59 Is a Novel Marker of Poor Prognosis and Promotes Malignant Progression of Ovarian Cancer by Inducing Annexin A2 Expression
Cited by 29
Related Papers
A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
|Journal of Ovarian Research|2014|545
Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort
|BMC Infectious Diseases|2020|177
Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis
|Journal of Experimental & Clinical Cancer Research|2019|146
Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy
|Theranostics|2020|116
MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKK /NF- B pathway and reduced interleukin-8 expression
|Molecular Human Reproduction|2011|94